Hugo Perez, MD
Obstetrics & Gynecology · Clearwater, FLNPI 1033293253
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Exeltis, USA Inc. at 28.1% of the total. Reporting peaked in 2021 at $248 and has fallen 90.1% since, to $25 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in FL, where the typical reported total is $820.
Across 21 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$136
- AbbVie$91
- Astellas Pharma US Inc$54
- Hologic Sales And Service, LLC$41
- Organon$34
- Pfizer$30
- plus $96 from 5 others
Across 152 payments — averaging $2681.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$332K
- Bayer$46K
- Ferring International Pharmascience Center US$29K
What the payments were for
- Food & beverage$44893%
- Education$347%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 2 | $136 |
| AbbVie(2 entities) | 5 | $91 |
| Astellas Pharma US Inc | 2 | $54 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Organon | 2 | $34 |
| Pfizer | 2 | $30 |
| Myovant Sciences Inc. | 2 | $28 |
| Coopersurgical, Inc. | 1 | $25 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Slynd$121
How this compares
$482 in reported general payments places this provider in the 35th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 77 | $2,240 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $260 |
| Metronidazole | 14 | $120 |
| Acyclovir | 11 | $75 |
| Fluconazole | 14 | $73 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Clearwater
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.